Why Is AMRIZE LTD (AMRZ) Stock Down Today?

Why AMRZ stock is down today

AMRZ stock fell 6.99% to $47.64 in early trading on August 7, 2026, driven by a sharp earnings miss and a raised but below-estimate revenue outlook. The stock opened with a 9.5% gap down from the prior close and has traded in a narrow range since. The earnings report and outlook revision appear to be the primary catalysts for the sell-off.

What Happened

Amrize Ltd reported Q2 adjusted earnings per share of $0.88, below the consensus estimate of $0.94. The company also announced revenue of $3.494 billion, which beat the $3.365 billion estimate but came with a warning that adjusted EPS fell short of expectations. In response, Amrize raised its full-year 2026 sales guidance to a range of $12.500B to $12.700B, still below the $12.464B estimate. The earnings call presentation and subsequent reports highlighted strong revenue and net income growth, but the earnings shortfall and cost pressures appear to have disappointed investors.

Amrize also announced a $0.11 quarterly dividend, consistent with its previous payout. The company declared this alongside the earnings report. Meanwhile, Oppenheimer maintained an Outperform rating on the stock but lowered its price target to $65.

What The Data Shows

The stock opened at $46.36, a sharp decline from the prior close of $51.22. It reached an intraday high of $48.78 at 9:30 AM ET but quickly fell to a low of $46.32. The session volume of 2.0 million shares is 70% of the 3-month average, indicating moderate but not unusual activity. Over the past eight sessions, the stock had risen 2.4% from $50.37 to $51.56, making the current decline particularly pronounced. Insiders have been net buyers in the last 90 days, with five purchases totaling $2.7 million and no sales reported.

What To Watch

The next key event for Amrize will be its upcoming earnings report if not already covered. Investors should also monitor coverage breadth and analyst reactions as the market digests the Q2 results and revised guidance.